Literature DB >> 18945606

Heroin in brown, black and white: structural factors and medical consequences in the US heroin market.

Daniel Ciccarone1.   

Abstract

BACKGROUND: Heroin coming into the United States historically comes from three widely dispersed geographical regions: Southwest Asia, Southeast Asia and Mexico. A fourth source of US-bound heroin, from Colombia, originated in the early 1990s. The fact that the four heroin sources produce differing morphologies and qualities of heroin has not been critically examined. In addition, it is not well established how the contemporary competing dynamics of interdiction, or restriction of heroin flows across international boundaries, and neoliberal, e.g., global expansion of free trade, policies are affecting heroin markets. This paper will highlight changes in the US heroin market, including source trends, the political economy of the now dominant source and the resultant effects on the heroin risk environment by US region.
METHODS: Using a structural and historical framework this paper examines two decades of secondary data sources, including government and drug control agency documents, on heroin flows together with published work on the political and economic dynamics in Latin America.
RESULTS: Co-occurring neoliberal economic reforms may have contributed to paradoxical effects of US/Colombian interdiction efforts. Since entering the US market, heroin from Colombia has been distributed at a much higher quality and lower retail price. An increasingly exclusive market has developed with Mexican and Colombian heroin gaining market share and displacing Asian heroin. These trends have had dramatic effects on the risk environment for heroin consumers. An intriguing factor is that different global sources of heroin produce substantially different products. Plausible associations exist between heroin source/form and drug use behaviours and harms. For example, cold water-soluble powdered heroin (sources: Asia, Colombia) may be associated with higher HIV prevalence in the US, while low-solubility "black tar" heroin (BTH; source: Mexico) is historically used in areas with reduced HIV prevalence. BTH is associated with soft tissue infections caused by Clostridium bacteria.
CONCLUSION: Source and type of heroin are structural factors in the risk environment of heroin users: source dictates distribution and type predicts practice. How specific types of heroin are used and with what risk is therefore distributed geographically. Continued flux in the heroin market and its effects on the risk environment for drug users deserves further attention.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18945606      PMCID: PMC2704563          DOI: 10.1016/j.drugpo.2008.08.003

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  24 in total

1.  High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco.

Authors:  I A Binswanger; A H Kral; R N Bluthenthal; D J Rybold; B R Edlin
Journal:  Clin Infect Dis       Date:  2000-03       Impact factor: 9.079

2.  Unexplained deaths among injection drug users: a case of probable Clostridium myonecrosis.

Authors:  N Williamson; C Archibald; J S Van Vliet
Journal:  CMAJ       Date:  2001-09-04       Impact factor: 8.262

Review 3.  Skin and soft tissue infections in injection drug users.

Authors:  John R Ebright; Barbara Pieper
Journal:  Infect Dis Clin North Am       Date:  2002-09       Impact factor: 5.982

Review 4.  Interpreting changes in heroin supply in Melbourne: droughts, gluts or cycles?

Authors:  Paul Dietze; John Fitzgerald
Journal:  Drug Alcohol Rev       Date:  2002-09

5.  The internationalization of police: the DEA in Mexico.

Authors:  M C Toro
Journal:  J Am Hist       Date:  1999

6.  Care of injection drug users with soft tissue infections in San Francisco, California.

Authors:  Hobart W Harris; David M Young
Journal:  Arch Surg       Date:  2002-11

7.  Wound botulism in California, 1951-1998: recent epidemic in heroin injectors.

Authors:  S B Werner; D Passaro; J McGee; R Schechter; D J Vugia
Journal:  Clin Infect Dis       Date:  2000-10-25       Impact factor: 9.079

8.  Heroin overdose deaths--Multnomah County, Oregon, 1993-1999.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2000-07-21       Impact factor: 17.586

9.  An overview of heroin trends in New York City: past, present and future.

Authors:  B Frank
Journal:  Mt Sinai J Med       Date:  2000 Oct-Nov

10.  Risk factors for skin and soft-tissue abscesses among injection drug users: a case-control study.

Authors:  E L Murphy; D DeVita; H Liu; E Vittinghoff; P Leung; D H Ciccarone; B R Edlin
Journal:  Clin Infect Dis       Date:  2001-06-05       Impact factor: 9.079

View more
  54 in total

1.  Illicit fentanyls in the opioid street market: desired or imposed?

Authors:  Sarah G Mars; Daniel Rosenblum; Daniel Ciccarone
Journal:  Addiction       Date:  2018-12-04       Impact factor: 6.526

2.  Prevalence and characteristics of femoral injection among Seattle-area injection drug users.

Authors:  Phillip O Coffin; Lara S Coffin; Shilo Murphy; Lindsay M Jenkins; Matthew R Golden
Journal:  J Urban Health       Date:  2012-04       Impact factor: 3.671

3.  High rates of transitions to injecting drug use among Mexican American non-injecting heroin users in San Antonio, Texas (never and former injectors).

Authors:  Avelardo Valdez; Alan Neaigus; Charles Kaplan; Alice Cepeda
Journal:  Drug Alcohol Depend       Date:  2010-11-13       Impact factor: 4.492

Review 4.  Opioid Use Disorder in Pregnancy: Health Policy and Practice in the Midst of an Epidemic.

Authors:  Elizabeth E Krans; Stephen W Patrick
Journal:  Obstet Gynecol       Date:  2016-07       Impact factor: 7.661

5.  Fentanyl in the US heroin supply: A rapidly changing risk environment.

Authors:  Daniel Ciccarone
Journal:  Int J Drug Policy       Date:  2017-07-20

6.  Determining spatial access to opioid use disorder treatment and emergency medical services in New Hampshire.

Authors:  Yanjia Cao; Kathleen Stewart; Eric Wish; Eleanor Artigiani; Marcella H Sorg
Journal:  J Subst Abuse Treat       Date:  2019-04-05

7.  Heroin uncertainties: Exploring users' perceptions of fentanyl-adulterated and -substituted 'heroin'.

Authors:  Daniel Ciccarone; Jeff Ondocsin; Sarah G Mars
Journal:  Int J Drug Policy       Date:  2017-07-18

8.  The entry of Colombian-sourced heroin into the US market: the relationship between competition, price, and purity.

Authors:  Daniel Rosenblum; George Jay Unick; Daniel Ciccarone
Journal:  Int J Drug Policy       Date:  2013-10-19

9.  Black Tar Heroin Skin Popping as a Cause of Wound Botulism.

Authors:  Ihtesham A Qureshi; Mohtashim A Qureshi; Mohammad Rauf Afzal; Alberto Maud; Gustavo J Rodriguez; Salvador Cruz-Flores; Darine Kassar
Journal:  Neurocrit Care       Date:  2017-12       Impact factor: 3.210

10.  The relationship between US heroin market dynamics and heroin-related overdose, 1992-2008.

Authors:  George Unick; Daniel Rosenblum; Sarah Mars; Daniel Ciccarone
Journal:  Addiction       Date:  2014-08-04       Impact factor: 6.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.